Skip to content
10-Q

Quarterly Report

Tengjun Biotechnology Corp.

0001213900-22-071678

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 9, 2022 96.31M sh
Shares Diluted Q3 2022 · Sep 30, 2022 88.68M sh
Shares Diluted Q3 2022 · Sep 30, 2022 73.18M sh
Shares Diluted Q3 2022 · Sep 30, 2021 19.29M sh
Shares Diluted Q3 2022 · Sep 30, 2021 19.29M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 $4.02M
Operating Cash Flow restated Q3 2022 · Sep 30, 2021 −$319.71K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $3.9M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $285.57K
Stockholders Equity Q3 2022 · Sep 30, 2022 $7.69M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$2.19M
Current Liabilities Q3 2022 · Sep 30, 2022 $27.66M
Current Liabilities Q3 2022 · Dec 31, 2021 $16.32M
Total Liabilities Q3 2022 · Sep 30, 2022 $27.66M
Total Liabilities Q3 2022 · Dec 31, 2021 $16.32M
Current Assets Q3 2022 · Sep 30, 2022 $27.22M
Current Assets Q3 2022 · Dec 31, 2021 $4.63M
Total Assets Q3 2022 · Sep 30, 2022 $35.66M
Total Assets Q3 2022 · Dec 31, 2021 $14.03M
Net Income Q3 2022 · Sep 30, 2022 $3.43M
Net Income Q3 2022 · Sep 30, 2022 $7.57M
Net Income restated Q3 2022 · Sep 30, 2021 −$107.3K
Net Income restated Q3 2022 · Sep 30, 2021 −$495.48K
Operating Income Q3 2022 · Sep 30, 2022 $4.88M
Operating Income Q3 2022 · Sep 30, 2022 $9.84M
Operating Income restated Q3 2022 · Sep 30, 2021 −$107.55K
Operating Income restated Q3 2022 · Sep 30, 2021 −$488.23K
Gross Profit Q3 2022 · Sep 30, 2022 $34.21M
Gross Profit Q3 2022 · Sep 30, 2022 $85.98M
Revenue Q3 2022 · Sep 30, 2022 $36.42M
Revenue Q3 2022 · Sep 30, 2022 $91.99M